No black box warning on record for Glyburide-Metformin Hydrochloride

As of the latest FDA labeling reviewed, Glyburide-Metformin Hydrochloride (GLYBURIDE-METFORMIN HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Glyburide-Metformin Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Lactic Acidosis: See boxed warning. ( 5.1 ) • Hypoglycemia: May be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications. ( 5.2 ) • Potential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefit

No black box warning on record for Glyburide-Metformin Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Lactic Acidosis: See boxed warning. ( 5.1 ) • Hypoglycemia: May be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications. ( 5.2 ) • Potential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefit

Glyburide-Metformin Hydrochloride Black Box Warning

No black box warning on record for Glyburide-Metformin Hydrochloride

Other warnings & precautions

Glyburide-Metformin Hydrochloride Black Box Warning

No black box warning on record for Glyburide-Metformin Hydrochloride

Other warnings & precautions